Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results
Every single imaging finding that can be disclosed on conventional and MR enteroclysis was correlated with the Crohn’s disease activity index (CDAI). Nineteen consecutive patients with Crohn’s disease underwent colon endoscopy and both conventional and MR enteroclysis examinations. Seventeen MR imaging findings and seven conventional enteroclysis findings were ranked on a four-point grading scale and correlated with CDAI, with a value of 150 considered as the threshold for disease activity. Six patients had active disease in the colon according to colon endoscopy. In the remaining 13 patients, the presence of deep ulcers (P=0.002), small bowel wall thickening (P=0.022) and gadolinium enhancement of mesenteric lymph nodes (P=0.014) identified on MR enteroclysis images were strongly correlated to disease activity. The product of deep ulcers and enhancement of lymph node ranks identified on MR enteroclysis were the optimum combination for discriminating active from non-active disease (F-test: 55.95, P<0.001). Additionally, the ranking of deep ulcers on conventional enteroclysis provided statistically significant differences between active and non-active patients (F-test: 14.12, P=0.004). Abnormalities strongly suggestive of active Crohn’s disease can be disclosed on MR enteroclysis examinations and may provide pictorial information for local inflammatory activity.
KeywordsMR imaging Activity Small bowel Inflammatory bowel disease
- 7.Faber SC, Stehling MK, Holzknecht N, Gauger J, Helmberger T, Reiser M (1997) Pathologic conditions in the small bowel: findings at fat-suppressed gadolinium-enhanced MR imaging with an optimized suspension of oral magnetic particles. Radiology 205:278–282Google Scholar
- 9.Schmidt S, Lepori D, Meuwly JY, Duvoisin B, Meuli R, Michetti P, Felley C, Schnyder P, van Melle G, Denys A (2003) Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of “sign-by-sign” correlation. Eur Radiol 13:1303–1311PubMedGoogle Scholar
- 14.Koh DM, Miao Y, Chinn RJ, Amin Z, Seegen R, Westaby D, Healy JC (2001) MR imaging evaluation of the activity in Crohn’s disease. Am J Roentgenol 177:1325–1332Google Scholar
- 15.Madsen SM, Thomsen HS, Munkholm P, Davidsen B, Dorph S, Nielsen SL, Schlichting P (2002) Inflammatory bowel disease evaluated by low-field magnetic resonance imaging. Comparison with endoscopy, 99mTc-HMPAO leucocyte scintigraphy, conventional radiography and surgery. Scand J Gastroenterol 37:307–316CrossRefPubMedGoogle Scholar
- 16.Yacyshyn BR, Chey WY, Goff J, Salzberg B, Baerg R, Buchman AL, Tami J, Yu R, Gibiansky E, Shanahan WR (2002) Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn’s disease. Gut 51:30–36CrossRefPubMedGoogle Scholar